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Abstract 
By using the immortalized microglial cell line BV-2, we show that the high expression of the PA4 amyloid precursor protein (APP), its biogenesis 
and metabolism is modulated by TGFj?, a cytokine with immunosuppressive activity, and by the microglia-stimulating agent LPS. TGFB induces 
accumulation of cellular mature APP, the putative precursor of the amyloid subunit of Alzheimer’s disease. LPS leads to an increase in cellular 
immature, non-amyloidogenic APP and secretion of also non-amyloidogenic APP fragments. We also demonstrate afunctional involvement of ECM 
molecules in the regulation of microglial APP expression at mRNA and protein level by TGFB and LPS. 
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1. Introduction 
Microglia are believed to be important effector cells in 
the immune response of the central nervous system [l-4]. 
They have attracted much attention because of their po- 
tential relevance for the pathogenesis of Alzheimer’s dis- 
ease. Activated microglia are able to synthesize large 
amounts of amyloid precursor protein (APP) [5-71 and 
are often associated with amyloid plaques in Alzheimer’s 
disease [S-lo]. The major component of the deposits is 
the /?A4 peptide (for reviews, see [11,12]). This amy- 
loidogenic peptide is derived by proteolytic cleavage 
from the larger transmembrane amyloid precursor pro- 
tein [13]. Soluble /?A4 protein can be detected in the 
extracellular mileu under normal, nonpathological con- 
ditions [33-351. 
APP constitutes a family of different isoforms that are 
generated by alternative splicing [13-181. The major pri- 
mary translation products consist of 695, 751, and 770 
amino acid residues as well as the recently described 
L-APP isoforms consisting of 677, 733, and 752 amino 
acids. All these APP/L-APP isoforms show the charac- 
teristic features of typical transmembrane glycoproteins. 
Major secreted forms of APP are generated by prote- 
olytic cleavage within the amyloidogenic region [19,20]. 
Axotomy studies have shown that the /3ACamyloid 
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precursor protein participates in immune responses of 
the central nervous system [6]. In injured brain, microglia 
possesses the immunomodulatory role of peripheral eu- 
kocytes [14]. Microglia share many antigenic markers 
and other properties with cells of the mononuclear pha- 
gocyte system [3]. Like peripheral macrophages, they 
produce and respond to a range of molecules that are 
involved in the modulation of immune response. TGF/?, 
a cytokine with potent immunosuppressive activity, has 
also been shown to be produced by microglia [21]. It has 
been suggested that TGF/I could be a negative regulator 
in cytokine network by inhibiting the function of micro- 
glia in inflammation or in immunoregulation [22,23]. 
However, cell responsiveness to growth and transform- 
ing factors is often controlled by components of the ex- 
tracellular matrix (ECM) [24]. Especially, cells of the 
mononuclear phagocytic system undergo a rapid and 
extensive change in the pattern of gene expression upon 
adherence to substrata coated with ECM proteins [25]. 
In this study we have analyzed the effect of the im- 
munosuppressive agent TGF/I and the effect of the mi- 
croglia-stimulating agent lipopolysaccharide in regard to 
microglial APP expression, biogenesis and metabolism. 
For our analysis we used the immortalized microglial cell 
line BV-2 which shares several features characteristic of 
activated microglia in vivo [26]. We could demonstrate 
that microglial cell-cell interactions and cell-ECM inter- 
actions were essential for regulating microglial APP bio- 
synthesis by the soluble mediators TGF/? and LPS. This 
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could be an important mechanism for the regulation of 
microglial ocalization and function in health and disease. 
2. Materials and methods 
2.1. Cell culture 
Cells of the mouse microglial cell line BV-2 [26] were studied in these 
experiments. Cells were maintained in Dulbecco’s modified Eagle’s 
medium (DMEM) supplemented with 10% fetal calf serum and 2 mM 
glutamine. For preparation of substratum-coated dishes, plates with a 
diameter of 60 mm were incubated for 12 h at 4°C with 20 &ml 
fibronectin, 20&ml laminin, or lOO&nl collagen type I, respectively. 
To set up experimental cultures on ECM-coated dishes, BV-2 micro- 
glial cells were removed by scraping and seeded in suspension at 5 x lo5 
cells per ml in 3.0 ml medium consisting of optiMEM (GibcolBRL, 
UK). 
2.2. Mitogen treatment 
Treatment of cells with mitogens was performed with 1 ng/ml trans- 
forming growth factor (TGFBl) (Serva, Heidelberg, Germany), and 5 
&ml lipopolysaccharide (LPS) (Sigma Chemical CO., St. Louis, MO) 
for 16 h. 
2.3. Immunoprecipitation and immunoblotting 
Conditioned medium was removed from the cell cultures, cleared by 
centrifugation and stored at -20°C. 2 x lo6 cells were collected by 
scraping in 1.5 ml phosphate-buffered saline (PBS) and were washed 
once with PBS. For lysis, cells were resuspended in 0.2 ml lysis buffer 
(50 mM Tris (PH 7.5), 150 mM NaCl, 2 mM EDTA, 1% Nonidet P40, 
1% Triton X-100, 2 mM phenylmethylsulfonylfluoride (PMSF), 10 
&ml aprotinin, 10 &ml leupeptin and 1,6 mgfml iodoacetamide) and 
incubated for 30 min on ice. Cell lysates were centrifuged at 10,000 x g 
for 5 min and the resulting supernatants were stored at -20°C until 
further use. The extraction pellet was discarded. 
For analysis of APP, cell lysates and conditioned media were sub- 
jected to immunoprecipitation. The cell lysate was diluted with an equal 
volume of ice-cooled PBS; conditioned medium was supplemented with 
75 ~1 medium buffer (1 M Tris (pH 8.0), 100 mM EDT& 10% Nonidet 
P40. 100 mM PMSF). Lvsate and medium were nreincubated for 2 h 
at room temperature (RT) with 10 ~1 pre-immune serum and 3 mg 
protein A-Sepharose (Pharmacia, Uppsala, Sweden). The insoluble 
complexes were discarded after centrifugation. Lysates and superna- 
tants were then incubated for 1 h at RT with 5 ~1 of undiluted anti-CT 
and anti-FdAPP antiserum, respectively. Anti-FdAPP is a polyclonal 
rabbit antiserum raised against purified E. coli FdAPP fusion protein 
[27]. The polyclonal anti-CT antiserum was raised against a synthetic 
peptide corresponding to the C-terminal 43 residues of APP 
After addition of 2 mg of protein A-Sepharose the mixture was 
incubated for 30 min at RT. Non-bound proteins were removed from 
sepharose beads by washing with TSA solution (20 mM Tris (PH 8.0), 
150 mM NaCl). The immunoprecipitates were fractionated by 7% SDS- 
PAGE [28] and transferred onto nitrocellulose [29]. The nitrocellulose 
sheet was soaked in PBS containing 1% bovine serum albumine (BSA) 
for 1 h at RT and then incubated at RT for 2 h with monoclonal 
antibody 22Cll (1:lOOOO) [27,38]. The nitrocellulose sheet was then 
washed three times with T&-buffered saline (10 mM Tris (PH 8.0), 150 
mM NaCl, 0.05% Tween 20). Specific binding was visualized with the 
Protoblot alkaline phosphatase system (Promega, Heidelberg, Ger- 
many). Quantitation of individual bands was performed by densitomet- 
ric scanning. 
2.4. Isolation of RNA, Northern hybridization 
Total RNA was prepared as described [30]. For each sample, 20 @g 
of total RNA was separated in a denaturing formaldehyde-containing 
1% agarose gel, and vacuum blotted to Gene-Screen-Plus (DuPont) 
nylon membrane following the manufacturer’s protocol. Filters were 
hybridized with an EcoRI-APPcDNA and a GAPDH cDNA restric- 
tion fragment labelled by nick translation using [a-“P]dCTP (Amer- 
sham). Prehybridization and hybridization buffer contained 0.5 M 
Na,HPO, (pH 7.4), 1% sodium dodecylsulfate, and 1% BSA. Hybridi- 
zation was performed overnight at 65°C and filters were washed three 
times in 40 mM Na,HPO,, pH 7.4 and 1% SDS at 65”C, and exposed 
to Kodak X-AR film for 4 d at -80°C. For quantitation of individual 
bands, gels were analyzed on a phosphorImager (Molecular Dynamics). 
3. Results 
3.1. Effect of extracellular matrix, TGFj and LPS on 
morphology of BV-2 cells 
The microglial cell line BV-2 showed a different mor- 
phology when cultivated on different ECM-coated plas- 
tic dishes (Fig. 1). Cultivation of microglia cells on plas- 
tic induced both spindle- and round-shaped morpholo- 
gies (Fig. la). Microglia cells cultivated on fibronectin 
showed a marked increase in extending processes (Fig. 
1 b). Microglial cells lost their characteristic morphology 
after being plated on laminin and collagen (Fig. lc,d). 
Round and small microglial cells were visibly lacking 
filopodial projections. Attachment to laminin was weak 
and not followed by spreading. On collagen cells were 
grown in suspension by forming partly big cell aggre- 
gates. 
Microglial cells cultivated on plastic and fibronectin 
revealed a significant morphologic transition upon treat- 
ment with the soluble mediators TGFB and LPS. The 
change in phenotypic bevahior was strongest by BV-2 
cells cultivated on fibronectin (Fig. le,f). As shown in 
Fig. le, addition of the TGF/3 to the culture medium 
induced the ‘ramified’ phenotype (Fig. le) whereas bac- 
terial lipopolysaccharide (LPS) induced the ‘ameboid’ 
phenotype (Fig. If). Microglial cells cultivated on lam- 
inin displayed only slight morphologic alteration after 
treatment with TGFP and LPS. No change in morphol- 
ogy was observed by microglia grown on collagen sub- 
stratum (not shown). 
a. b. 
cl. a. f. 
Fig. 1. Morphology of the microglial cell line BV-2 grown on different 
substrates. Phase contrast micrographs of these cells were photo- 
graphed after 16 h of cultivation in FCS-reduced medium (magnifica- 
tion 1:50): a. cell culture plastic, b. fibronectin (20 &ml), c. laminin 
(20 &ml), d. collagen (100 @nl). Morphologic alterations of cells 
cultivated on fibronectin in presence of TGFB and LPS were shown in 
e and f, respectively. 
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3.2. Effect ofTGFB and LPS on APP gene expression 
The effects of TGF/$ and LPS on total APP gene ex- 
pression in microglial cells ~tivated on different matri- 
ces were analyzed by Northern blotting using an APP 
cDNA restriction fragment and a glyceraldehyde-3- 
phosphate dehydrogenase (GAPDH) cDNA restriction 
fragment as a control. Visual inspection of autoradi- 
ogramms indicated (Fig. 2A) that TGFB and LPS in- 
creased the absolute amount of APP mRNA (detected as 
a 3,4 kb band) transcripts under all investigated culture 
conditions, but the strength of APP expression differed 
in dependence on the chosen coating protein. However, 
changes in level of GAPDH mRNA transcripts (detected 
as 1,6 kb band) reflecting the overall rate of protein 
synthesis, were also observed after treatment with TCFP 
and LPS but in other extent than observed for APP 
transcripts, The selective effects on APP expression of 
microglial cells were uncovered by comparison of the 
steady-state levels of APP transcripts and levels of 
GAPDH transcripts. For this RNA bands were quanti- 
tated by use of a PhosphorImager and the ratio of APP 
to GAPDH mRNA band intensity calculated (Fig. 2b). 
Changes in this ratio reflect specific changes in APP 
mRNA expression. Microglia cultivated on non-coated 
plastic culture plates exhibited the highest ratio of APPl 
GAPDH expression, The ratio of APP/G~DH was 
generally 50% to 70% lower in microglia cultivated on 
ECM-coated plates. The selective effects of TGFB and 
LPS on APP expression of microglial cells cultivated on 
fibronectin, laminin, collagen and non-coated plates are 
graphically shown in Fig. 2~. Treatment of microglia 
grown on plastic and collagen with TGFj3 led to a de- 
crease of APP expression of about 17%. An increase in 
APPmRNA expression was observed by microglia 
grown on laminin (+ 30%) and in highest extent by mi- 
crogha grown on fibron~tin (+ 80%). LPS induced 
under all c~tivation conditions an increase in APP ex- 
pression but to different extents. The LPS-induced in- 
crease in APP expression was lowest by microglia grown 
on uncoated plates (+ 7%), and reached maximum val- 
ues by microglia cultivated on laminin and fibronectin 
(+ 103 and f 116%, respectively). The results demon- 
strate a fictional involvement of ECM molecules in 
mediating cellular responses to TGFj? and LPS with re- 
gard to microgiial APP expression. Regarding the distri- 
bution of alternatively spliced APP mRNA isoforms, 
however, quantitative RT-PCR analysis [IS] revealed no 
si~ifi~ant differen~s within these ~~erently cultivated 
microglial cells (results not shown). 
3.3. Effect of TGFB and LPS on APP biogenesis and 
metabolism 
To investigate whether TGFj? and LPS actions are 
associated with changes in APP biogenesis and metabo- 
lism, we examined cells and conditions media with re- 
gard to APP content by imrnunoprecipitation and subse- 
APP 
GAPDH 
a. 
b. 
C. 
Fig. 2. Effect of TGFB and LPS on APP mRNA expression of micro- 
glial cells cultivated on different ECM. (a) Analysis of total APP 
mRNA expression of BV-2 Cetls cultivated under different cultivation 
monitions. BV-2 cells were cuitivated in the absence (control) or in the 
presence of TGF/3 and LPS, respectively, on different ECM-coated 
substrata for 16 h. Cells were harvested and total cellular RNA was 
isolated. RNA samples (20 pg) were separated on agarose gels, trans- 
ferred onto nitroeellulose membranes, and subjected to Northern blot 
hyb~d~tion using 3zP-lab-eled cDNA probes specific for human APP, 
or GAPDH as a control. (b) No~~ation of APP mRNA expression. 
For normalization of APP mRNA, individual signals corresponding to 
APP transcripts and GAPDH transcripts were quantitated on a 
phosphorimager by overnight exposure. The relative change in APP 
expression was expressed as the ratio of APP transcripts to GAPDH 
transcripts. (c) Specific effect of TGF& and LPS on APPmRNA expres- 
sion. For the detection of spe&k effects of TGEjs and LPS on 
APPmRNA expression, changes in the ratio of APP to GAPDH tran- 
scripts in comparison to the respective control culture in the absence 
of TGF/? and LPS were estimated for different ECM substrata (in %). 
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tn.,. APP 
Immai. APP 
sec. APP 
quent Western blotting. The results are shown in Fig. 3a. 
BV-2 expressed transmembrane APP isoforms in the pre- 
dominant molecular mass range of 95-l 30 kDa and 140- 
145 kDa, corresponding to all described major transla- 
tion products of the APP gene. APPs in the molecular 
weight range of 95-130 kDa represent mainly immature 
(partially glycosylated) APP whereas the higher APP 
isoforms represent mature (fully glycosylated) trans- 
membrane products [5,27]. Secretory APP isoforms, re- 
leased in conditioned medium, were detected in the mo- 
lecular weight range of 125-135 kDa. Relative levels of 
immature and mature APP isoforms and the level of 
respective secretory APP observed under different culti- 
vation conditions were determined by densitometric 
scanning (Fig. 3b and c). 
a. medium 
- jm immature APP 
n 
plastk fibronectin laminin collagen 
b. 
phtk fibro laminin toll 
Cells cultivated on tissue culture plastic did not show 
significant differences in intracellular APP biogenesis in 
the presence of TGF/? and LPS. No significant differ- 
ences in the ratio of immature APP to mature APP were 
observed. APP secretion was only slightly affected. In 
contrast, APP biogenesis of cells cultivated on fi- 
bronectin, laminin and also collagen highly sensitive to 
the mitogens used. Treatment of cells with the cytokine 
TGFB increased the appearance of mature transmem- 
brane APP isoforms. Cells cultivated on laminin and 
collagen showed the greatest accumulation of mature 
transmembrane APP in the presence as well as in the 
absence of TGFB. The ratio of mature transmembrane 
APP to immature transmembrane APP was in general 
markedly higher in TGFB-treated cells than in control 
cells. This might indicate that transmembrane APP accu- 
mulated on the cell surface of TGF/?-treated cells. Secre- 
tion was slightly suppressed by cells cultivated on fi- 
bronectin and collagen. LPS, known to induce pha- 
gocytic activity in microglial cells in vitro, caused an 
increase in the amount of cellular immature transmem- 
brane APP. In the presence of LPS, the amount of ma- 
ture transmembrane APP was comparable to control 
cells (in the case of laminin or collagen) or slightly in- 
creased (in the case of fibronectin). High amounts of 
immature and, concomitantly, low amounts of mature 
APP may reflected a higher turn over rate of transmem- 
brane APP. This is also evidenced by the significant in- 
t 
Fig. 3. Effect of TGFB and LPS on APP biogenesis of microghal cells 
cultivated on different ECM. (a) Western blot analysis of APP from cell 
lysates and supernatants. Microglial cells were cultivated for 16 h on 
different substrates without or in the presence of TGF/I (1 ng/ml) and 
LPS (5 pgjml). APP of detergent extracts from cells (top panel) and 
conditioned media (bottom panel) was immunoprecipitated, electro- 
phoresed on a 7% SDS-gel and analyzed by Western blotting as de- 
scribed in section 2. (b) Quantitation of cellular immature and mature 
APP isoforms. Quantitation was done by densitometric scanning anal- 
ysis of the immunoblot presented in the top panel of a. The relative 
amounts of APP are represented in arbitrary units. (c) Quantitation of 
secretory APP. Quantitation of the bottom panel of a was done as 
described in b. 
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crease of APP secretion after treatment with LPS. The 
fact that cells cultivated on laminin and collagen gener- 
ally revealed a higher level of mature transmembrane 
APP and a lower level in secretory APP can be explained 
by an impairment in APP metabolic and catabolic proc- 
esses based on a disorgan~ation of the cytoskeleton (un- 
published obse~ations). 
In addition to a transcriptional regulation of APP ex- 
pression by TGF/I and LPS, the results also point to a 
possible posttranslational control of APP biogenesis and 
metabolism by soluble mediators. 
4. Discussion 
Based on the observations made in this study on the 
retroviral immortalized microglial cell line BV-2 we con- 
clude that APP is an impo~ant component in the func- 
tional behavior of microligal cells within the immune 
response of the central nervous system. We revealed a 
critical role of cell-ECM interaction in regulating micro- 
glial APP biogenesis and metabolism upon addition of 
growth and differentiation factors. The responsiveness of
microglial cells to soluble factors is controlled by compo- 
nents of the extracellular matrix. Microglial cells culti- 
vated on plastic culture dishes do not show significant 
changes in APP mRNA expression as well as APP bio- 
genesis and metabolism after treatment with TGFB and 
LPS. In contrast, microglial cells grown on ECM sub- 
strata like fibronectin, laminin and collagen were highly 
sensitive to TGF/I and LPS treatment. Transforming 
growth factor b which has been proposed to have im- 
munosuppressive ffects on microglia cells led to an in- 
crease in cellular mature transmembrane APP. In con- 
trast, the microglia activating mitogen lipopolysac- 
charide enhanced secretion of APP under all ECM culti- 
vation conditions, but not on untreated plastic culture 
dishes. RNA analysis of the appropriate microglial cells 
has shown that both TGFB and LPS have an enhancing 
effect on microglial APP mRNA expression, but gener- 
ally LPS to a higher extent than TGFB. Since microglial 
cells grew in suspension by forming cell aggregates when 
culture dishes were precoated with collagen, we suggest 
that cellcell interactions, possibly based on interactions 
of cells with cell-associated extracellular matrix, are re- 
sponsible for increased responsiveness to TGF,8 and 
LPS, rather than interactions of cells with collagen. This 
is also supported by the fact that microglia cells grown 
on plastic culture dishes in high density cultures (in- 
creased cell-cell interactions) show a significantly higher 
responsiveness to TGF/3 and LPS than microglia grown 
in low density cultures (impaired cell-cell interactions) 
(unpublished observations). 
Our findings support the hypothesis that growth and 
differentiation factors like TGFfi and LPS may act syn- 
ergistically or complementary through signals initiated 
by ECMcell or cell-11 interactions. Microglia requires 
at least one additional signal for modulating APP bio- 
synthesis in response to soluble mediators. The parallel 
effects of TGFB and LPS on APP gene expression and 
APP biogenesis suggest the involvement of transcrip- 
tional as well as posttranscriptional events in this re- 
sponse. 
The results presented here confirm that APP plays a 
fundamental role in the migratory behavior of microglial 
cells. Nevertheless, transmembrane APP and secreted 
APP possess different functional acitivity within micro- 
glial behavior. It is likely that regulative factors like 
TGF/I and LPS change the balance of the two functional 
states of APP by modulation of APP expression and 
processing. As shown in this study, mature transmem- 
brane APP forms were predominantly observed upon 
addition of TGFB. Treatment of BV-2 cells with TGFB 
in the presence of fibronectin induced the ‘ramified’ phe- 
notype which often reflects an inactive state of microglia 
[31]. Indeed, it has been shown that TGFB suppresses 
activation and proliferation of microglia [22,23]. There- 
fore, we suggest that mature transmembrane APP might 
be needed irectly as cell-surface receptor transducing 
extracellular signals, e.g. chemotactic signals or activa- 
tion signals, to the interior of the cells. In contrast, acti- 
vation of microglia with LPS (activated ‘ameboid’ phe- 
notype) induced increased secretion of APP pointing to 
a key role of secretory APP in initial pathfinding activi- 
ties, target recognition and binding. This is in excellent 
agreement with results obtained from the analysis of 
APP biosynthetic behavior of peripheral blood T-lym- 
phocytes [5,32]: APP as an inducible molecule is secreted 
by T-lymphocytes directly upon stimulation with mito- 
genie lectins, such as phytohemagglutinin (PHA) sug- 
gesting an impo~ant role of secretory APP in initial 
processes of T-cell related immune responses. 
Thus, the results presented here confirm and extend 
our earlier conclusion that APP plays a fundamental role 
in the initial processes of immune responses of the pe- 
riphery and the central nervous system. Since microglia 
are often closely associated with amyloid plaques in Alz- 
heimer’s disease [&-IO], it is suggested that microglial 
APP and APP fragments are involved in the generation 
of amyloid plaques. Accumulation of cellular transmem- 
braneous (amyloidogenic) APP caused by environmental 
changes might be a prerequisite for starting amy- 
loidogenesis. Since it is known that expression of TGFB 
is associated with immune responses of the central nerv- 
ous system [36,37], it is an intriguing hypothesis that 
TGF/? might play a modulatory key role in these proc- 
esses. High expression of TGF/I in association with 
changes in the extracellular matrix, such as increased 
expression of collagen upon brain injury, could cause an 
increase in amyloidogenic transmembrane APPs and of 
its break-down product, the soluble j3A4. This could 
start the process of preclinical amyloid generation if the 
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concentration of PA4 surpasses the threshold for its ag- 
gregation. 
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